Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Intermolecular Inc    IMI

INTERMOLECULAR INC

(IMI)
SummaryQuotesNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

INTERMOLECULAR INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
08/08/2019 | 04:23pm EDT

ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On August 8, 2019, Intermolecular, Inc. (the "Company") issued a press release announcing its financial results for the second quarter ended June 30, 2019. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information furnished in Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except expressly set forth by specific reference in such filing.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

The following exhibit relating to Item 2.02 shall be deemed to be furnished and not filed:

99.1 Press Release dated August 8, 2019, entitled " Intermolecular Reports Second Quarter 2019 Financial Results "

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on INTERMOLECULAR INC
2019INTERMOLECULAR : Merck Completes Acquisition of Intermolecular
AQ
2019INTERMOLECULAR INC : Completion of Acquisition or Disposition of Assets, Notice ..
AQ
2019INTERMOLECULAR : 2Q Earnings Snapshot
AQ
2019INTERMOLECULAR : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
2019INTERMOLECULAR INC : Results of Operations and Financial Condition, Financial St..
AQ
2019INTERMOLECULAR : Reports Second Quarter 2019 Financial Results
PR
2019INTERMOLECULAR TO LEAD SESSION ON 3D : Current Implementations and Future Trends..
PR
2019Intermolecular Stockholders Agree to Merck KGaA Acquisition
DJ
2019INTERMOLECULAR INC : Submission of Matters to a Vote of Security Holders, Other ..
AQ
2019INTERMOLECULAR : Stockholders Approve Merck KGaA, Darmstadt, Germany's Proposed ..
PR
More news
Chart INTERMOLECULAR INC
Duration : Period :
Intermolecular Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers
NameTitle
Casper van Oosten President & Chief Executive Officer
Milind Weling Senior Vice President-Programs & Operations
Bill Roeschlein Chief Financial Officer & Senior Vice President
Karl Littau Chief Technology Officer
Luiz Vieira Director
Sector and Competitors
1st jan.Capitalization (M$)
INTERMOLECULAR INC18.32%59
INTEL CORPORATION-7.28%237 331
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LIMITED-0.19%229 143
NVIDIA CORPORATION12.87%162 541
BROADCOM INC.-24.02%95 994
TEXAS INSTRUMENTS-20.48%95 255